
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
A. 510(k) Number:
K161573
B. Purpose for Submission:
To obtain a substantial equivalence determination for the FilmArray RP EZ Control Panel
M265.
C. Measurand:
Multi-analyte quality control materials
D. Type of Test:
FilmArray RP EZ Control Panel M265 is intended for in vitro diagnostic use as external
assayed quality control materials to monitor the qualitative amplification, detection and
identification steps of the laboratory nucleic acid test, FilmArray RP EZ assay on the
FilmArray 2.0 instrument, which detects respiratory pathogens: Adenovirus, Coronavirus,
Human Metapneumovirus, Human Rhinovirus/ Enterovirus, Influenza A, Influenza A
subtype H1, Influenza A subtype H3, Influenza A subtype H1-2009, Influenza B,
Parainfluenza Virus, Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila
pneumoniae, and Mycoplasma pneumoniae.
E. Applicant:
Maine Molecular Quality Controls, Inc. (MMQCI)
F. Proprietary and Established Names:
FilmArray RP EZ Control Panel M265
G. Regulatory Information:
1. Regulation section:
21 CFR 866.3920, Assayed quality control material for clinical microbiology assays
2. Classification:
Class II (Special Controls)
1

--- Page 2 ---
3. Product code:
PMN
4. Panel:
83- Microbiology
H. Indication(s) for use:
1. Indications for use(s):
FilmArray RP EZ Control Panel M265 is intended for use as an external positive and
negative assayed quality control to monitor the performance of in vitro laboratory nucleic
acid testing procedures for the qualitative detection of Adenovirus, Coronavirus, Human
Metapneumovirus, Human Rhinovirus/ Enterovirus, Influenza A, Influenza A subtype
H1, Influenza A subtype H3, Influenza A subtype H1-2009, Influenza B, Parainfluenza
Virus, Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila pneumoniae,
and Mycoplasma pneumoniae on the FilmArray RP EZ assay performed on the
FilmArray systems. FilmArray RP Positive Control is composed of synthetic RNA
transcripts specifically designed for and intended to be used solely with the FilmArray
RP EZ assay. This product is not intended to replace manufacturer controls provided with
the device.
2. Special conditions for use statement(s):
For in vitro diagnostic use only
For prescription use only
3. Special instrument requirements:
The FilmArray RP EZ Control Panel M265 was evaluated on FilmArray 2.0 instrument.
I. Device Description:
FilmArray RP EZ Control Panel M265 is a quality control panel consisting of two controls:
FilmArray RP EZ Positive Control and FilmArray RP EZ Negative Control. The Positive
Control contains non-infectious surrogate control material; a solution of synthetic RNA in
buffers, stabilizers and preservatives. The RNA carries segments of all respiratory pathogens
detected by the FilmArray RP EZ assay (see Table below) on the FilmArray instrument 2.0
EZ Configuration system. The RNA in the Negative Control is non-specific RNA in buffers,
stabilizers and preservatives. Each liquid control of FilmArray RP EZ Control Panel M265 is
processed separately according to FilmArray RP EZ assay manufacturer’s Instructions for
Use for patient samples (nasopharyngeal swabs (NPS) obtained from individuals suspected
of respiratory tract infection and placed in Viral Transport Media (VTM)).
2

--- Page 3 ---
The FilmArray RP EZ Positive Control M265 is prepared nucleic acid concentrations of 3X-
10X LoD for each of the organisms detected by the FilmArray RP EZ assay.
Respiratory pathogens detected by FilmArray RP EZ assay
Adenovirus Influenza A H1-2009
Coronavirus Influenza B
Human Metapneumovirus Parainfluenza Virus
Human Rhinovirus/ Enterovirus Respiratory Syncytial Virus
Influenza A Bordetella pertussis
Influenza A subtype H1 Chlamydophila pneumoniae
Influenza A subtype H3 Mycoplasma pneumoniae
J. Substantial Equivalence Information:
1. Predicate device name(s):
Amplichek II, Bio-Rad Laboratories
2. Predicate 510(k) number(s):
DEN150058
3. Comparison with predicate:
Similarities
Item FilmArray RP EZ Control Panel Amplichek II
M265 (K161573) (DEN150058)
3

[Table 1 on page 3]
Respiratory pathogens detected by FilmArray RP EZ assay	
Adenovirus	Influenza A H1-2009
Coronavirus	Influenza B
Human Metapneumovirus	Parainfluenza Virus
Human Rhinovirus/ Enterovirus	Respiratory Syncytial Virus
Influenza A	Bordetella pertussis
Influenza A subtype H1	Chlamydophila pneumoniae
Influenza A subtype H3	Mycoplasma pneumoniae

[Table 2 on page 3]
Similarities		
Item	FilmArray RP EZ Control Panel
M265 (K161573)	Amplichek II
(DEN150058)

--- Page 4 ---
Intended Use FilmArray RP EZ Control Panel M265 is Amplichek II is intended for use as
intended for use as external positive and an external assayed quality control
negative, surrogate assayed quality control material to monitor the
materials to monitor the performance of in performance of in vitro laboratory
nucleic acid testing procedures for
vitro laboratory nucleic acid testing
the qualitative detection of
procedures for the qualitative detection of
Methicillin Resistant
Adenovirus, Coronavirus, Human
Staphylococcus aureus, Methicillin
Metapneumovirus, Human Rhinovirus/
Sensitive Staphylococcus aureus,
Enterovirus, Influenza A, Influenza A
Clostridium difficile and
subtype H1, Influenza A subtype H3,
Vancomycin-resistant Enterococci
Influenza A subtype H1-2009, Influenza B,
performed on Cepheid GeneXpert
Parainfluenza Virus, Respiratory Syncytial
Systems. This product is not
Virus, Bordetella pertussis, Chlamydophila
intended to replace manufacturer
pneumoniae, and Mycoplasma pneumonia on controls provided with the device.
the FilmArray RP EZ assay performed on the This product is only for use with
FilmArray systems. The control panel also assays and instruments listed in the
contains a negative control. This product is Representative Results Chart in this
not intended to replace manufacturer controls labeling.
provided with the device.
Similarities
Item FilmArray RP EZ Amplichek II
Control Panel M265 (DEN150058)
Directions for Use Process li(kKe1 p6a1t5ie7n3t) Same
sample Same
Number of targets Multiplex Same
monitored in one assay
Differences
Item FilmArray RP EZ Control Amplichek II
Panel M265 (K161573) (DEN150058)
Composition Synthetic RNA Intact microorganisms
Assay Steps Same except does not Extraction, reverse
Monitored monitor extraction transcription, amplification,
detection, identification
K. Standard/Guidance Document Referenced (if applicable):
None were referenced
4

[Table 1 on page 4]
Intended Use	FilmArray RP EZ Control Panel M265 is
intended for use as external positive and
negative, surrogate assayed quality control
materials to monitor the performance of in
vitro laboratory nucleic acid testing
procedures for the qualitative detection of
Adenovirus, Coronavirus, Human
Metapneumovirus, Human Rhinovirus/
Enterovirus, Influenza A, Influenza A
subtype H1, Influenza A subtype H3,
Influenza A subtype H1-2009, Influenza B,
Parainfluenza Virus, Respiratory Syncytial
Virus, Bordetella pertussis, Chlamydophila
pneumoniae, and Mycoplasma pneumonia on
the FilmArray RP EZ assay performed on the
FilmArray systems. The control panel also
contains a negative control. This product is
not intended to replace manufacturer controls
provided with the device.		Amplichek II is intended for use as
an external assayed quality control
material to monitor the
performance of in vitro laboratory
nucleic acid testing procedures for
the qualitative detection of
Methicillin Resistant
Staphylococcus aureus, Methicillin
Sensitive Staphylococcus aureus,
Clostridium difficile and
Vancomycin-resistant Enterococci
performed on Cepheid GeneXpert
Systems. This product is not
intended to replace manufacturer
controls provided with the device.
This product is only for use with
assays and instruments listed in the
Representative Results Chart in this
labeling.
Similarities			
Item		FilmArray RP EZ
Control Panel M265	Amplichek II
(DEN150058)
Directions for Use		Process li(kKe1 p6a1t5ie7n3t)
sample Same	Same
Number of targets
monitored in one assay		Multiplex	Same

[Table 2 on page 4]
Differences		
Item	FilmArray RP EZ Control
Panel M265 (K161573)	Amplichek II
(DEN150058)
Composition	Synthetic RNA	Intact microorganisms
Assay Steps
Monitored	Same except does not
monitor extraction	Extraction, reverse
transcription, amplification,
detection, identification

--- Page 5 ---
L. Test Principle:
Not applicable
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Reproducibility:
A multi-site reproducibility study was performed with the FilmArray RP EZ Control
Panel M265 on FilmArray instrument 2.0 EZ Configuration system at two CLIA-
waived clinical sites and one simulated CLIA-waived test site (e.g., testing was
performed at a laboratory with users that were screened to have training and
educational backgrounds consistent with those in the CLIA-waived testing
environment). Testing consisted of three positive and three negative controls run per
day, and spanned a period of 10 days (total of 60 control runs per site). Multiple
operators participated in testing at each of the three locations. Three lots each of
external control material and three lots of RP EZ pouches were tested across all sites.
A total of 182 external controls were tested (91 positive and 91 negative). Two tests
were excluded from the final data analysis due to Invalid results caused by internal
pouch control failures. The results are shown in the tables below:
FilmArray RP EZ Control Panel Summary of External Reproducibility Test Results
All Sites All Sites
SITE
Site #1 Site #2 Site #3 Overall 95%
Category #expected % #expected % #expected % Percent Confidence
results/# Agreement results/# Agreement results/# Agreement Agreement Interval
tested1 with tested with tested with
Expected Expected Expected
Result 1 Result 1 Result 1
FilmArray 30/30 100% 30/30 100% 30/30 100% 100% 95.9% to
RP EZ 90/90 100%
Positive
Control
FilmArray 30/30 100% 30/30 100% 28/303 93.3% 97.78% 92.3% to
RP EZ 88/90 99.4%
Negative
Control
1 Expected result for the FilmArray RP EZ Positive Control is positive. Expected result for the FilmArray RP EZ Negative
Control is negative.
2 The 2 Invalid samples were re-tested according to BioFire instructions and were not included in the Percent Correct
analysis.
3 Two false positives were observed with the FilmArray RP EZ Negative Control at site #3. The detected organisms were 1)
Coronavirus CoV-NL63, 2) Coronavirus CoV-229E. The FilmArray RP EZ assay only reports Coronavirus as Detected or
Not Detected.
5

[Table 1 on page 5]
	FilmArray RP EZ Control Panel Summary of External Reproducibility Test Results									
Category		SITE						All Sites	All Sites	
								Overall
Percent
Agreement	95%
Confidence
Interval	
		Site #1		Site #2		Site #3				
		#expected
results/#
tested1	%
Agreement
with
Expected
Result 1	#expected
results/#
tested	%
Agreement
with
Expected
Result 1	#expected
results/#
tested	%
Agreement
with
Expected
Result 1			
FilmArray
RP EZ
Positive
Control		30/30	100%	30/30	100%	30/30	100%	100%
90/90	95.9% to
100%	
FilmArray
RP EZ
Negative
Control		30/30	100%	30/30	100%	28/303	93.3%	97.78%
88/90	92.3% to
99.4%	

--- Page 6 ---
Crossing Point (Cp) data for FilmArray RP EZ Control Panel External Reproducibility Study
Respiratory Site Site 2 Site All Sites
Pathogen 1 3
Mean Cp SD Mean Cp SD Mean Cp SD Mean Cp SD
Analyte
Adeno 22.6 1.2 22.0 1.3 22.2 1.2 22.3 1.2
Adeno2 21.0 1.1 20.6 1.2 20.7 1.0 20.8 1.1
CoV-229E1 20.9 0.7 20.5 1.1 20.5 0.8 20.6 0.9
CoV-HKU11 19.8 1.1 19.3 1.1 19.4 0.8 19.5 1.0
CoV-NL631 19.6 1.5 18.8 1.0 18.9 0.7 19.1 1.1
CoV-OC431 19.4 0.8 19.0 1.2 18.9 0.6 19.1 0.9
hMPV 21.8 1.3 21.4 1.4 21.2 1.0 21.5 1.2
Entero1 20.4 1.0 20.0 1.1 20.0 0.8 20.1 1.0
Entero2 20.4 1.2 20.0 1.1 20.0 0.8 20.1 1.0
HRV1 17.5 0.7 17.2 1.1 16.9 0.7 17.2 0.8
HRV2 18.0 0.7 17.7 1.0 17.4 0.7 17.7 0.8
HRV3 22.7 0.9 22.6 1.3 21.8 0.7 22.4 1.0
HRV4 19.5 0.9 19.2 1.0 18.9 0.6 19.2 0.8
FluA-H1-2009 18.7 1.2 18.2 1.1 18.2 0.8 18.4 1.0
FluA-H1-pan 18.8 1.1 18.3 1.1 18.4 0.8 18.5 1.0
FluA-H3 18.1 0.8 17.7 1.2 17.6 0.9 17.8 1.0
FluA-pan1 19.7 0.8 19.2 1.1 19.1 0.7 19.3 0.9
FluA-pan2 20.0 1.0 19.5 1.1 19.5 0.6 19.7 0.9
FluB 19.3 0.7 18.9 1.2 18.7 0.7 19.0 0.9
PIV1 20.5 1.4 19.7 1.3 19.9 0.9 20.0 1.2
PIV2 20.1 0.9 19.8 1.1 19.6 0.6 19.8 0.9
PIV3 18.8 0.9 18.4 1.1 18.2 0.6 18.5 1.1
PIV4 19.2 1.2 18.6 1.3 18.5 0.8 18.8 1.1
RSV 18.8 0.8 18.4 1.2 18.1 0.7 18.4 0.9
Bper 20.9 0.8 20.5 1.0 20.5 0.7 20.6 0.8
Cpne 19.0 0.8 18.5 1.2 18.4 0.7 18.6 0.9
Mpne 19.5 1.2 18.7 1.2 18.6 0.7 18.9 1.0
The results suggest that there are no significant differences between different users
and different sites on different days. External reproducibility studies for the
FilmArray RP EZ Control Panel M265 are acceptable.
b. Precision:
An internal precision study for the FilmArray RP EZ Control Panel M265 was
conducted over multiple days by testing three FilmArray RP EZ Control Panel lots
with four FilmArray RP EZ assay lots performed by one operator. The results are
shown in the table below:
6

[Table 1 on page 6]
Crossing Point (Cp) data for FilmArray RP EZ Control Panel External Reproducibility Study								
Respiratory
Pathogen
Analyte	Site		Site 2		Site		All Sites	
	1
Mean Cp	SD	Mean Cp	SD	Mean Cp	3
SD	Mean Cp	SD
Adeno	22.6	1.2	22.0	1.3	22.2	1.2	22.3	1.2
Adeno2	21.0	1.1	20.6	1.2	20.7	1.0	20.8	1.1
CoV-229E1	20.9	0.7	20.5	1.1	20.5	0.8	20.6	0.9
CoV-HKU11	19.8	1.1	19.3	1.1	19.4	0.8	19.5	1.0
CoV-NL631	19.6	1.5	18.8	1.0	18.9	0.7	19.1	1.1
CoV-OC431	19.4	0.8	19.0	1.2	18.9	0.6	19.1	0.9
hMPV	21.8	1.3	21.4	1.4	21.2	1.0	21.5	1.2
Entero1	20.4	1.0	20.0	1.1	20.0	0.8	20.1	1.0
Entero2	20.4	1.2	20.0	1.1	20.0	0.8	20.1	1.0
HRV1	17.5	0.7	17.2	1.1	16.9	0.7	17.2	0.8
HRV2	18.0	0.7	17.7	1.0	17.4	0.7	17.7	0.8
HRV3	22.7	0.9	22.6	1.3	21.8	0.7	22.4	1.0
HRV4	19.5	0.9	19.2	1.0	18.9	0.6	19.2	0.8
FluA-H1-2009	18.7	1.2	18.2	1.1	18.2	0.8	18.4	1.0
FluA-H1-pan	18.8	1.1	18.3	1.1	18.4	0.8	18.5	1.0
FluA-H3	18.1	0.8	17.7	1.2	17.6	0.9	17.8	1.0
FluA-pan1	19.7	0.8	19.2	1.1	19.1	0.7	19.3	0.9
FluA-pan2	20.0	1.0	19.5	1.1	19.5	0.6	19.7	0.9
FluB	19.3	0.7	18.9	1.2	18.7	0.7	19.0	0.9
PIV1	20.5	1.4	19.7	1.3	19.9	0.9	20.0	1.2
PIV2	20.1	0.9	19.8	1.1	19.6	0.6	19.8	0.9
PIV3	18.8	0.9	18.4	1.1	18.2	0.6	18.5	1.1
PIV4	19.2	1.2	18.6	1.3	18.5	0.8	18.8	1.1
RSV	18.8	0.8	18.4	1.2	18.1	0.7	18.4	0.9
Bper	20.9	0.8	20.5	1.0	20.5	0.7	20.6	0.8
Cpne	19.0	0.8	18.5	1.2	18.4	0.7	18.6	0.9
Mpne	19.5	1.2	18.7	1.2	18.6	0.7	18.9	1.0

--- Page 7 ---
FilmArray RP EZ Control Panel Summary of Internal Precision Test Results
Operator #1 Combined
Category #expected results/ % Agreement with Overall Percent 95% Confidence
#tested1 Expected Result 1 Agreement Interval
FilmArray 39/39 100% 100% 91% to 100%
RP EZ Positive
Control
FilmArray 49/49 100% 100% 92.7% to 100%
RP EZ Negative
Control
Crossing Point (Cp) data for FilmArray RP EZ Control Panel External Precision Study
Respiratory Control Lot#: Control Lot#: Control Lot#: All Lots
Pathogen M40DEC15A A28DEC15A A06JAN16A
Analyte
Mean Cp SD Mean Cp SD Mean Cp SD Mean Cp SD
Adeno 22.1 1.1 21.9 1.4 21.6 0.6 21.4 0.5
Adeno2 20.2 0.7 19.9 1.1 19.7 0.4 19.5 0.3
CoV-229E1 19.7 0.6 19.5 0.6 19.4 0.5 19.2 0.1
CoV-HKU11 18.5 0.7 18.4 0.6 18.2 0.4 18.0 0.2
CoV-NL631 18.1 0.4 18.0 0.5 17.9 0.4 17.8 0.3
CoV-OC431 18.1 0.3 17.9 0.5 17.9 0.4 17.8 0.4
hMPV 21.4 0.8 21.0 1.0 21.1 0.4 21.1 0.4
Entero1 19.1 0.7 19.1 0.8 18.9 0.4 19.1 0.3
Entero2 19.0 0.6 19.0 0.8 18.9 0.4 19.1 0.3
HRV1 16.2 0.1 16.0 0.4 16.0 0.4 16.0 0.3
HRV2 17.1 0.2 16.8 0.4 16.9 0.4 16.8 0.3
HRV3 24.9 1.6 23.6 1.9 23.8 1.7 22.9 0.5
HRV4 19.9 0.5 19.6 0.7 19.9 0.4 20.0 0.4
FluA-H1-2009 17.2 0.6 17.1 0.6 16.8 0.4 16.6 0.3
FluA-H1-pan 18.1 0.8 17.8 0.8 17.5 0.5 17.3 0.4
FluA-H3 17.6 0.5 17.2 0.6 17.3 0.3 17.2 0.3
FluA-pan1 18.5 0.4 18.2 0.4 18.4 0.4 18.5 0.4
FluA-pan2 19.0 0.5 18.7 0.4 18.6 0.3 18.5 0.3
FluB 18.1 0.4 17.9 0.4 17.8 0.5 17.6 0.4
PIV1 18.8 0.7 18.8 0.8 18.3 0.3 18.2 0.3
PIV2 19.0 0.3 18.8 0.4 18.8 0.6 18.4 0.4
PIV3 17.9 0.5 17.4 0.5 17.6 0.4 17.5 0.4
PIV4 19.2 0.7 18.7 0.9 18.9 0.5 18.9 0.7
RSV 17.6 0.2 17.4 0.5 17.5 0.4 17.4 0.4
Bper 19.9 0.4 19.7 0.8 19.7 0.4 19.6 0.4
Cpne 17.6 0.2 17.4 0.3 17.6 0.4 17.5 0.4
Mpne 17.8 0.2 17.6 0.4 17.7 0.5 17.6 0.4
7

[Table 1 on page 7]
FilmArray RP EZ Control Panel Summary of Internal Precision Test Results					
Category	Operator #1		Combined		
	#expected results/
#tested1	% Agreement with
Expected Result 1	Overall Percent
Agreement	95% Confidence
Interval	
FilmArray
RP EZ Positive
Control	39/39	100%	100%	91% to 100%	
FilmArray
RP EZ Negative
Control	49/49	100%	100%	92.7% to 100%	

[Table 2 on page 7]
Crossing Point (Cp) data for FilmArray RP EZ Control Panel External Precision Study								
Respiratory
Pathogen
Analyte	Control Lot#:
M40DEC15A		Control Lot#:
A28DEC15A		Control Lot#:
A06JAN16A		All Lots	
	Mean Cp	SD	Mean Cp	SD	Mean Cp	SD	Mean Cp	SD
Adeno	22.1	1.1	21.9	1.4	21.6	0.6	21.4	0.5
Adeno2	20.2	0.7	19.9	1.1	19.7	0.4	19.5	0.3
CoV-229E1	19.7	0.6	19.5	0.6	19.4	0.5	19.2	0.1
CoV-HKU11	18.5	0.7	18.4	0.6	18.2	0.4	18.0	0.2
CoV-NL631	18.1	0.4	18.0	0.5	17.9	0.4	17.8	0.3
CoV-OC431	18.1	0.3	17.9	0.5	17.9	0.4	17.8	0.4
hMPV	21.4	0.8	21.0	1.0	21.1	0.4	21.1	0.4
Entero1	19.1	0.7	19.1	0.8	18.9	0.4	19.1	0.3
Entero2	19.0	0.6	19.0	0.8	18.9	0.4	19.1	0.3
HRV1	16.2	0.1	16.0	0.4	16.0	0.4	16.0	0.3
HRV2	17.1	0.2	16.8	0.4	16.9	0.4	16.8	0.3
HRV3	24.9	1.6	23.6	1.9	23.8	1.7	22.9	0.5
HRV4	19.9	0.5	19.6	0.7	19.9	0.4	20.0	0.4
FluA-H1-2009	17.2	0.6	17.1	0.6	16.8	0.4	16.6	0.3
FluA-H1-pan	18.1	0.8	17.8	0.8	17.5	0.5	17.3	0.4
FluA-H3	17.6	0.5	17.2	0.6	17.3	0.3	17.2	0.3
FluA-pan1	18.5	0.4	18.2	0.4	18.4	0.4	18.5	0.4
FluA-pan2	19.0	0.5	18.7	0.4	18.6	0.3	18.5	0.3
FluB	18.1	0.4	17.9	0.4	17.8	0.5	17.6	0.4
PIV1	18.8	0.7	18.8	0.8	18.3	0.3	18.2	0.3
PIV2	19.0	0.3	18.8	0.4	18.8	0.6	18.4	0.4
PIV3	17.9	0.5	17.4	0.5	17.6	0.4	17.5	0.4
PIV4	19.2	0.7	18.7	0.9	18.9	0.5	18.9	0.7
RSV	17.6	0.2	17.4	0.5	17.5	0.4	17.4	0.4
Bper	19.9	0.4	19.7	0.8	19.7	0.4	19.6	0.4
Cpne	17.6	0.2	17.4	0.3	17.6	0.4	17.5	0.4
Mpne	17.8	0.2	17.6	0.4	17.7	0.5	17.6	0.4

--- Page 8 ---
There appears to be no significant differences in mean Cp value when testing different
control lots on different days. Precision studies are acceptable.
c. Within-run Testing:
Within-run reproducibility was demonstrated in a separate study conducted by one
operator testing two lots of FilmArray RP EZ Control Panel M265 with one lot of
FilmArray RP EZ pouches on the FilmArray 2.0, each within one day. The results are
shown in the tables below:
8

--- Page 9 ---
FilmArray RP EZ Control Panel Summary of Within-run Reproducibility Results
No. of Pouch Correct
Control Control Lot#
Tests Lot Results
FilmArray RP EZ Positive Control A06JAN16A 6 239115 6/6 (100%)
FilmArray RP EZ Negative Control M41DEC15A 5 239115 5/5 (100%)
Crossing Point (Cp) data for FilmArray RP EZ Control Panel Within-run Reproducibility
Respiratory Pathogen FilmArray RP EZ Positive Control (Lot A06JAN16A)
Analyte Mean Cp SD
Adeno 21.4 0.5
Adeno2 19.5 0.3
CoV-229E1 19.2 0.1
CoV-HKU11 18.0 0.2
CoV-NL631 17.8 0.3
CoV-OC431 17.8 0.4
hMPV 21.1 0.4
Entero1 19.1 0.3
Entero2 19.1 0.3
HRV1 16.0 0.3
HRV2 16.8 0.3
HRV3 22.9 0.5
HRV4 20.0 0.4
FluA-H1-2009 16.6 0.3
FluA-H1-pan 17.3 0.4
FluA-H3 17.2 0.3
FluA-pan1 18.5 0.4
FluA-pan2 18.5 0.3
FluB 17.6 0.4
PIV1 18.2 0.3
PIV2 18.4 0.4
PIV3 17.5 0.4
PIV4 18.9 0.7
RSV 17.4 0.4
Bper 19.6 0.4
Cpne 17.5 0.4
Mpne 17.6 0.4
9

[Table 1 on page 9]
FilmArray RP EZ Control Panel Summary of Within-run Reproducibility Results				
				
Control	Control Lot#	No. of
Tests	Pouch
Lot	Correct
Results
FilmArray RP EZ Positive Control	A06JAN16A	6	239115	6/6 (100%)
FilmArray RP EZ Negative Control	M41DEC15A	5	239115	5/5 (100%)

[Table 2 on page 9]
Crossing Point (Cp) data for FilmArray RP EZ Control Panel Within-run Reproducibility		
Respiratory Pathogen
Analyte	FilmArray RP EZ Positive Control (Lot A06JAN16A)	
	Mean Cp	SD
Adeno	21.4	0.5
Adeno2	19.5	0.3
CoV-229E1	19.2	0.1
CoV-HKU11	18.0	0.2
CoV-NL631	17.8	0.3
CoV-OC431	17.8	0.4
hMPV	21.1	0.4
Entero1	19.1	0.3
Entero2	19.1	0.3
HRV1	16.0	0.3
HRV2	16.8	0.3
HRV3	22.9	0.5
HRV4	20.0	0.4
FluA-H1-2009	16.6	0.3
FluA-H1-pan	17.3	0.4
FluA-H3	17.2	0.3
FluA-pan1	18.5	0.4
FluA-pan2	18.5	0.3
FluB	17.6	0.4
PIV1	18.2	0.3
PIV2	18.4	0.4
PIV3	17.5	0.4
PIV4	18.9	0.7
RSV	17.4	0.4
Bper	19.6	0.4
Cpne	17.5	0.4
Mpne	17.6	0.4

--- Page 10 ---
Within-run reproducibility studies for the FilmArray RP EZ Control Panel M265 are
acceptable.
d. Lot-to-Lot Testing:
Lot-to-lot reproducibility was demonstrated by testing three lots of FilmArray RP EZ
Positive Control using the same pouch lot. Results are shown in the following tables.
FilmArray RP EZ Control Panel Summary of Lot-to-Lot Reproducibility Results
Control Lot # Number of Tests Pouch Lot Correct Results
M40DEC15A 4 238915 4/4 (100%)
A28DEC15A 3 238915 3/3 (100%)
A06JAN16A 5 (1 Invalid) 238915 4/4 (100%)
Crossing Point (Cp) data for FilmArray RP EZ Control Panel Lot-to-Lot Reproducibility
Respiratory M40DEC15A A28DEC15A A06JAN16A All Lots All Lots
Pathogen Mean Cp Mean Cp Mean Cp Mean Cp SD
Analyte
Adeno 21.6 20.8 21.7 21.4 0.5
Adeno2 19.8 18.8 19.7 19.5 0.6
CoV-229E1 19.3 18.8 19.4 19.2 0.4
CoV-HKU11 18.1 17.7 18.4 18.1 0.4
CoV-NL631 18.1 17.7 18.1 18.0 0.4
CoV-OC431 18.3 17.5 18.2 18.0 0.5
hMPV 21.1 20.1 20.8 20.7 0.6
Entero1 18.4 18.0 18.5 18.3 0.4
Entero2 18.4 18.0 18.5 18.3 0.4
HRV1 16.2 15.8 16.2 16.1 0.4
HRV2 17.1 16.6 17.2 17.0 0.4
HRV3 25.6 24.2 25.3 25.1 1.9
HRV4 19.6 18.9 19.6 19.4 0.5
FluA-H1-2009 16.9 16.4 16.8 16.7 0.3
FluA-H1-pan 17.8 17.1 17.7 17.5 0.4
FluA-H3 17.4 16.6 17.4 17.2 0.5
FluA-pan1 18.5 17.8 18.4 18.3 0.4
FluA-pan2 18.7 18.3 18.6 18.5 0.3
FluB 17.9 17.4 18.0 17.8 0.4
PIV1 18.5 18.0 18.3 18.3 0.4
PIV2 19.1 18.4 19.3 19.0 0.5
PIV3 17.8 17.1 17.8 17.6 0.4
PIV4 19.2 17.9 18.8 18.7 0.7
RSV 17.7 17.1 17.7 17.6 0.4
Bper 19.7 19.1 19.8 19.6 0.5
10

[Table 1 on page 10]
FilmArray RP EZ Control Panel Summary of Lot-to-Lot Reproducibility Results			
Control Lot #	Number of Tests	Pouch Lot	Correct Results
M40DEC15A	4	238915	4/4 (100%)
A28DEC15A	3	238915	3/3 (100%)
A06JAN16A	5 (1 Invalid)	238915	4/4 (100%)

[Table 2 on page 10]
Crossing Point (Cp) data for FilmArray RP EZ Control Panel Lot-to-Lot Reproducibility					
Respiratory
Pathogen
Analyte	M40DEC15A	A28DEC15A	A06JAN16A	All Lots	All Lots
	Mean Cp	Mean Cp	Mean Cp	Mean Cp	SD
					
Adeno	21.6	20.8	21.7	21.4	0.5
Adeno2	19.8	18.8	19.7	19.5	0.6
CoV-229E1	19.3	18.8	19.4	19.2	0.4
CoV-HKU11	18.1	17.7	18.4	18.1	0.4
CoV-NL631	18.1	17.7	18.1	18.0	0.4
CoV-OC431	18.3	17.5	18.2	18.0	0.5
hMPV	21.1	20.1	20.8	20.7	0.6
Entero1	18.4	18.0	18.5	18.3	0.4
Entero2	18.4	18.0	18.5	18.3	0.4
HRV1	16.2	15.8	16.2	16.1	0.4
HRV2	17.1	16.6	17.2	17.0	0.4
HRV3	25.6	24.2	25.3	25.1	1.9
HRV4	19.6	18.9	19.6	19.4	0.5
FluA-H1-2009	16.9	16.4	16.8	16.7	0.3
FluA-H1-pan	17.8	17.1	17.7	17.5	0.4
FluA-H3	17.4	16.6	17.4	17.2	0.5
FluA-pan1	18.5	17.8	18.4	18.3	0.4
FluA-pan2	18.7	18.3	18.6	18.5	0.3
FluB	17.9	17.4	18.0	17.8	0.4
PIV1	18.5	18.0	18.3	18.3	0.4
PIV2	19.1	18.4	19.3	19.0	0.5
PIV3	17.8	17.1	17.8	17.6	0.4
PIV4	19.2	17.9	18.8	18.7	0.7
RSV	17.7	17.1	17.7	17.6	0.4
Bper	19.7	19.1	19.8	19.6	0.5

--- Page 11 ---
Crossing Point(Cp)data forFilmArray RP EZ Control Panel Lot-to-LotReproducibility
Respiratory M40DEC15A A28DEC15A A06JAN16A All Lots All Lots
Pathogen Mean Cp Mean Cp Mean Cp Mean Cp SD
Analyte
Cpne 17.6 17.1 17.8 17.5 0.4
Mpne 17.9 17.3 18.0 17.8 0.5
Lot-to-Lot reproducibility studies for the FilmArray RP EZ Control Panel M265 are
acceptable.
e. Linearity/assay reportable range:
Not applicable
f. Traceability, Stability, Expected values (controls, calibrators, or methods):
Traceability:
Not applicable
Stability:
Open Vial Stability: Not applicable because FilmArray RP EZ Control Panel M265 is
packaged for single use.
Closed Vial Real-time Stability: An accelerated stability study was performed to
establish the shelf life stability claims for FilmArray RP EZ Control Panel M265.
Based on this study, the FilmArray RP EZ Control Panel M265 is expected to be
stable until the expiration date (12 months) when stored frozen (– 20°C or colder) and
unopened. This product is for single use.
Real-Time Stability Program: Real-time stability studies are ongoing to support
product claims and to monitor potential assay modifications for which the FilmArray
RP EZ Control Panel M265 is indicated for use. Real-time stability study protocols
and acceptance criteria were reviewed and found to be acceptable.
Shipping Stability: MMQCI ships the FilmArray RP EZ Control Panel on dry ice with
overnight delivery, ensuring that the control material remains frozen upon receipt.
The frozen control material is then to be stored at -20oC, as indicated in the
FilmArray RP EZ Control Panel Package insert. A shipping study was performed to
confirm the shipping process and to investigate the outcome of a possible shipping
delay and subsequent arrival with no dry ice. The study evaluated two (2) lots of the
FilmArray RP EZ Positive Control placed in dry ice and was stored for two (2) days
at ambient temperature then tested using the FilmArray RP EZ Assay. To simulate a
shipping delay, two (2) lots of the FilmArray RP EZ Positive Control M266 were
11

[Table 1 on page 11]
Crossing Point(Cp)data forFilmArray RP EZ Control Panel Lot-to-LotReproducibility					
Respiratory
Pathogen
Analyte	M40DEC15A	A28DEC15A	A06JAN16A	All Lots	All Lots
	Mean Cp	Mean Cp	Mean Cp	Mean Cp	SD
					
Cpne	17.6	17.1	17.8	17.5	0.4
Mpne	17.9	17.3	18.0	17.8	0.5

--- Page 12 ---
stored for up to 6 days at ambient temperature and tested using the FilmArray RP EZ
Assay.
The study demonstrated that the FilmArray RP EZ Positive Control M265 is stable
for two (2) days on dry ice in MMQCI’s standard shipping box. FilmArray RP EZ
Positive Control is stable after five (5) days at ambient temperatures of approximately
19-21°C. The FilmArray RP EZ Positive Control should be stored frozen (–20°C or
colder) as indicated in the package insert.
Expected Values:
FilmArray RP EZ Control Panel M265 is a qualitative control and the expected
results are listed in the tables below.
FilmArray RP EZ Positive Control FilmArray Result Summary
Multiple Organisms Detected. Influenza A – Multiple Subtypes
Detected
Results Summary
Detected Not Detected
Adenovirus
Coronavirus
Human Metapneumovirus Human
Rhinovirus
Enterovirus
Influenza A H1-2009
Influenza A H3
Influenza B Parainfluenza Virus
Respiratory Syncytial Virus
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae
12

[Table 1 on page 12]
Multiple Organisms Detected. Influenza A – Multiple Subtypes
Detected	
Results Summary	
Detected	Not Detected
Adenovirus
Coronavirus
Human Metapneumovirus Human
Rhinovirus
Enterovirus
Influenza A H1-2009
Influenza A H3
Influenza B Parainfluenza Virus
Respiratory Syncytial Virus
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae	
	

--- Page 13 ---
FilmArray RP EZ Negative Control FilmArray Result Summary
Negative
Results Summary
Detected Not Detected
Adenovirus
Coronavirus
Human Metapneumovirus
Human Rhinovirus
Enterovirus Influenza A
Influenza B
Parainfluenza Virus
Respiratory Syncytial Virus
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae
Matrix Effects:
A study was performed to evaluate the effect of the FilmArray RP EZ Control Panel
M265 in the presence of viral transport media (VTM). Equal volumes of the same
concentration of inactivated Influenza A H1N1-2009 were spiked into 300μL of VTM
as well as 300μL of FilmArray RP EZ Negative Control, which contains the identical
matrix found in the FilmArray RP EZ Positive Control. Both sample types of the
H1N1-2009 were tested in triplicate by the FilmArray RP EZ assay.
Results demonstrated that samples prepared with FilmArray RP EZ Control Panel
M265 matrix generate equivalent results to samples prepared with VTM. Study
results are shown in the table below:
Respiratory Spiked BEI H1N1-2009 Crossing Point (Cp) Data
Pathogen Mean Mean
VTM MMQCI Matrix
Analyte Cp Cp
-
FluA-H1-2009 16.9 17.2 17.2 17.1 17.4 16.3 16.5 16.7
FluA-H1-pan 18.1 18.5 18.2 18.3 18.7 17.5 17.4 17.8
FluA-pan1 13.9 13.6 14.5 14.0 12.4 12.8 12.7 12.6
FluA-pan2 19.1 19.3 19.6 19.4 18.9 18.2 18.6 18.5
13

[Table 1 on page 13]
Negative	
Results Summary	
Detected	Not Detected
	Adenovirus
Coronavirus
Human Metapneumovirus
Human Rhinovirus
Enterovirus Influenza A
Influenza B
Parainfluenza Virus
Respiratory Syncytial Virus
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae
	

[Table 2 on page 13]
Respiratory	Spiked BEI H1N1-2009 Crossing Point (Cp) Data							
Pathogen				Mean				Mean
	VTM				MMQCI Matrix			
Analyte				Cp				Cp
								
FluA-H1-2009	16.9	-
17.2	17.2	17.1	17.4	16.3	16.5	16.7
FluA-H1-pan	18.1	18.5	18.2	18.3	18.7	17.5	17.4	17.8
FluA-pan1	13.9	13.6	14.5	14.0	12.4	12.8	12.7	12.6
FluA-pan2	19.1	19.3	19.6	19.4	18.9	18.2	18.6	18.5

--- Page 14 ---
g. Detection limit:
Not applicable
h. Analytical Reactivity (Inclusivity):
Not applicable
i. Cross Reactivity:
Not applicable
j. Interference:
Not applicable
k. Assay cut-off:
Not applicable.
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable.
3. Clinical Studies:
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable.
4. Clinical cut-off:
Not Applicable.
14

--- Page 15 ---
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Parts 801 and 809 and
the specials controls for this device type.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
15